Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VTYX
#2091
Ventyx Biosciences, Inc. Common Stock
13.9
7
-0.07%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.07%
Monthly Change
-0.07%
6 month change
+454.37%
Cambio anual
+837.58%
Cierres anteriores
13.9
8
Open
13.9
7
Bid
Ask
Low
13.9
7
High
13.9
7
Volumen
75
Markets
Acciones
Atención Sanitaria
VTYX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
50.73 M
58.21 M
59.25 M
71.13 M
—
Valuation ratios
Enterprise value
936.7 M
1.65 B
95.96 M
128.51 M
492.53 M
Price to earnings ratio
—
-14.26
-0.75
-1.11
-5.27
Price to sales ratio
—
—
—
1 102.7
—
Price to cash flow ratio
—
-15.68
-0.88
-1.15
-5.77
Price to book ratio
—
4.38
0.6
0.59
1.06
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.29
0.29
0.69
0.49
0.44
Return on equity %
0.3
0.31
0.79
0.53
0.48
Return on invested capital %
—
—
—
—
—
Gross margin %
—
—
—
100
—
Operating margin %
—
—
—
109.15 K
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
—
—
99.35 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
21.41
20.21
11.87
17.97
74.53
Inventory turnover
—
—
—
—
—
Asset turnover
—
—
—
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
0
—
—
—
Long term debt to total equity ratio
—
0
—
—
—
Per share metrics
Operating cash flow per share
—
1.88
2.84
1.91
1.25
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
6.8
4.31
3.69
12.55
Net current asset value per share
—
6.3
4.52
3.35
12.66
Tangible book value per share
—
6.74
4.17
3.71
12.59
Working capital per share
—
5.99
4.14
3.17
11.98
Book value per share
—
6.74
4.17
3.71
12.59
Noticias
Lilly Stock Jumps After Q4 Earnings Beat and Strong 2026 Guidance
Ventyx Biosciences aprueba bonos para ejecutivos previo a fusión planeada
Ventyx Biosciences aprueba bonificaciones en efectivo para ejecutivos antes de fusión planeada
Ventyx Biosciences approves cash bonus awards for executives ahead of planned merger
Why Eli Lilly Is The IBD Stock Of The Day — Again — As Its Novo Nordisk Rivalry Deepens
Dow Jones Retail Giant Amazon Stock Eyes Latest Buy Point
BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio
Eli Lilly Stock Broke Out Following Plan To Acquire Ventyx Biosciences
Stock Market Rallies Broadly To Highs; Nvidia, AMD, Bloom Energy In Focus: Weekly Review
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
Biotech Stocks' Dark Winter Is Over. What That Means For Investors.
Eli Lilly (LLY) Buys Ventyx Biosciences in $1.2 Billion Deal - TipRanks.com